Litcius/Paper detail

High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy

Laurent Dercle, Samy Ammari, Elvire Roblin, Amélie Bigorgne, Stéphane Champiat, Lokmane Taihi, Athèna Plaian, Sophie Hans, Sara Lakiss, Lambros Tsélikas, Mathieu Rouanne, Éric Deutsch, Lawrence H. Schwartz, Mithat Gönen, Jessica Flynn, Christophe Massard, Jean‐Charles Soria, Caroline Robert, Aurélien Marabelle

2022European Journal of Cancer43 citationsDOI

Topics & Concepts

MedicineInternal medicineImmunotherapyMelanomaClinical trialCancerMultivariate analysisOncologyGastroenterologyPopulationEnvironmental healthCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementImmunotherapy and Immune Responses
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy | Litcius